Understanding Shiga Toxin-Producing E. coli Infections in the Netherlands
Author Information
Author(s): Ingrid HM Friesema, Menno van der Voort, Ben Wit, Angela HAM van Hoek, Maaike JC van den Beld, Coen van der Weijden, Eelco Franz
Primary Institution: Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Hypothesis
What are the sources and reservoirs of human infections with Shiga toxin-producing Escherichia coli in the Netherlands?
Conclusion
The study highlights a lack of insight into the sources of Shiga toxin-producing E. coli infections in humans, suggesting that more effort is needed to identify under-recognized reservoirs.
Supporting Evidence
- STEC is a zoonotic pathogen that can cause severe illness.
- Cross-sectoral data sharing can improve understanding of infection sources.
- International travel significantly contributes to STEC infections in the Netherlands.
- Whole genome sequencing is a powerful tool for outbreak investigation.
- Only 5% of clusters contained both human and non-human isolates.
Takeaway
This study looks at how people can get sick from a germ called E. coli, which can come from animals and food, and shows that we need to find out more about where it comes from.
Methodology
The study evaluated cross-sectoral genomic surveillance data from human and non-human sources to identify potential sources of STEC infections.
Potential Biases
There may be biases due to the reliance on laboratory-confirmed cases and the decline in isolate availability for typing.
Limitations
The study is limited by the low success rate of matching human cases with animal or food isolates and the potential under-recognition of sources.
Participant Demographics
The study includes data from human cases of STEC infections reported in the Netherlands from 2017 to 2023.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website